Skip to content

Personalis, Inc. PSNL Market capitalization

Market capitalization at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$21.53B+14.7%
NeoGenomics logo
NeoGenomicsNEO
$963.21M-21.0%
Illumina logo
IlluminaILMN
$18.85B+50.0%
Veracyte logo
VeracyteVCYT
$2.56B+10.7%
Guardant Health logo
Guardant HealthGH
$12.12B+130%
Natera, Inc. logo
Natera, Inc.NTRA
$28.34B+48.3%

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Enterprise value$1.16B+115%
P/S18.4×+11.8×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Computed from the period-end share price: $666.5M.

The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Personalis, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Personalis, Inc.'s market capitalization?
Personalis, Inc. (PSNL) reported market capitalization of $666.5M in Q1 2026.
How has Personalis, Inc.'s market capitalization changed year-over-year?
Personalis, Inc.'s market capitalization increased by 115.1% year-over-year, from $309.8M to $666.5M.
What is the long-term trend for Personalis, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Personalis, Inc.'s market capitalization has grown at a -15.5% compound annual growth rate (CAGR), from $1.64B to $706.88M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.